- Lobbying
- Lobbying by JR Automation
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Eric Tober | Staff Asst House Mem (Bruce); Sen Project Dir (Johnston) Staff Asst House Mem (Bruce); Sen Project Dir (Johnston) |
Mark Mioduski | Prof Staff; House Approps Cmte (Obey) Prof Staff; House Approps Cmte (Obey) |
William Todd | Prof Staff Member Senate Approps Cmte, Legislative Aide, Legislative Asst, Dep Legislative Director Senate Member (Cochran) |
Susan Sweat | LC, LA & LD House Office (Wicker); LD Senate Member Office (Wicker) |
Anthony Lazarski | Senior Legislative Advisor, Senate Member Office (Inhofe); Professional Staff Member, Senate Armed Services Committee; Military Legislative Assistant, Senate Member Office (Inhofe) |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
Army - Dept of (Other)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
Army - Dept of (Other)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
Army - Dept of (Other)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
Army - Dept of (Other)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
Army - Dept of (Other)
Type of Issue
Registration
Issue(s) they said they’d lobby about: Automation of manufacturing for high demand medical devices and equipment for novel COVID response.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate